Scheda del titolo
VRNA
Verona Pharma plc · Healthcare · Biotechnology
17Holder monitorati
-1Δ titolari
15.38MQuote detenute
$1.64BValore dichiarato
+3Nuove posizioni
−4Uscite
Input di momentum (manager comparabili):
ampiezza dei detentori -5.6% ·
flusso azionario -4.7% ·
nuove posizioni nette -5.9%
— formula
Distribuzione diffusa — azioni in calo e minor numero di detentori
Tutte le cifre di proprietà: solo gestori 13F monitorati, posizioni in azioni ordinarie, periodo di riferimento Q3 2025
Proprietà nel tempo
| Trimestre | Detentori | Δ | Quote | Valore dichiarato | Nuovo | Uscite |
|---|---|---|---|---|---|---|
| Q3 2025 | 17 | -1 | 15.38M | $1.64B | +3 | −4 |
| Q2 2025 | 15 | +1 | 9.80M | $926.97M | +1 | — |
| Q1 2025 | 12 | +1 | 8.25M | $524.09M | +1 | — |
| Q4 2024 | 11 | +3 | 8.58M | $398.41M | +3 | — |
| Q3 2024 | 8 | -1 | 5.38M | $154.86M | +1 | −2 |
| Q2 2024 | 9 | — | 3.45M | $49.92M | — | — |
Chi lo detiene · Q3 2025
| # | Gestore | Quote | Δ azioni | Valore | Il loro peso | Detenuto | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passivo) | 3.83M | +1013.4% | $408.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passivo) | 3.83M | +1013.4% | $408.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passivo) | 3.83M | +1013.4% | $408.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passivo) | 3.83M | +1013.4% | $408.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passivo) | 3.83M | +1013.4% | $408.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passivo) | 3.83M | +1013.4% | $408.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passivo) | 3.83M | +1013.4% | $408.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 2.83M | — | $301.94M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | JPMorgan Chase ✦ | 2.83M | — | $301.94M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 2.83M | — | $301.94M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 2.83M | — | $301.94M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 2.83M | — | $301.94M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | JPMorgan Chase ✦ | 2.83M | — | $301.94M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | JPMorgan Chase ✦ | 2.83M | — | $301.94M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | JPMorgan Chase ✦ | 2.83M | — | $301.94M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | JPMorgan Chase ✦ | 2.83M | — | $301.94M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 2.83M | — | $301.94M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Goldman Sachs Group ✦ | 1.94M | — | $206.51M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Goldman Sachs Group ✦ | 1.94M | — | $206.51M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Millennium Management ✦ | 1.80M | +376.4% | $191.73M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 1.58M | — | $168.16M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 1.58M | — | $168.16M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 1.58M | — | $168.16M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 1.58M | — | $168.16M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 1.58M | — | $168.16M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 1.58M | — | $168.16M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 1.58M | — | $168.16M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 1.58M | — | $168.16M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 1.58M | — | $168.16M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Duquesne Family Office ✦ | 1.00M | 0.0% | $106.93M | 2.7% | Held | 5 | SEC ↗ |
| 31 | Renaissance Technologies ✦ | 615.90K | +317.8% | $65.72M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 461.87K | -66.9% | $49.29M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 461.87K | -66.9% | $49.29M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 34 | D. E. Shaw & Co. ✦ | 337.14K | -76.2% | $35.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 35 | Soros Fund Management ✦ | 285.19K | Nuovo | $30.43M | 0.7% | New | 1 | SEC ↗ |
| 36 | Arrowstreet Capital ✦ | 185.30K | Nuovo | $19.77M | 0.0% | New | 1 | SEC ↗ |
| 37 | GAMCO Investors ✦ | 163.80K | Nuovo | $17.48M | 0.2% | New | 1 | SEC ↗ |
| 38 | Marshall Wace ✦ | 147.77K | +460.8% | $15.77M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 39 | Marshall Wace ✦ | 147.77K | +460.8% | $15.77M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 40 | State Street Global Advisors ✦ (passivo) | 74.35K | +1076.4% | $7.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | Geode Capital Management ✦ (passivo) | 72.14K | +5.4% | $7.70M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 42 | Two Sigma Investments ✦ | 50.00K | -85.7% | $5.34M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 43 | Wellington Management ✦ | 18.63K | -98.9% | $1.99M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 44 | Wellington Management ✦ | 18.63K | -98.9% | $1.99M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 45 | Wellington Management ✦ | 18.63K | -98.9% | $1.99M | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Il loro peso" = la quota della posizione sul valore azionario 13F dichiarato da quel gestore — la misura di convinzione. ✦ = gestore selezionato.
Nuovi acquirenti
| Soros Fund Management | $30.43M | 0.7% |
| Arrowstreet Capital | $19.77M | 0.0% |
| GAMCO Investors | $17.48M | 0.2% |
Uscito
| T. Rowe Price | $169.25M | era 0.0% |
| Adage Capital Partners | $77.24M | era 0.1% |
| Fidelity (FMR) | $29.55M | era 0.0% |
| Point72 Asset Management | $11.22M | era 0.0% |
Frequentemente co-detenuti
Cosa detengono più spesso gli altri holder monitorati di questo titolo — conteggi di proprietà condivisa, non relazioni fondamentali.
Provenienza: Proprietà ricavata dalle posizioni in azioni ordinarie 13F analizzate (universo monitorato, set comparabili per le variazioni); righe insider dai Moduli 3/4/5; partecipazioni dagli Schedule 13D/13G; ogni filing rimanda all'originale su SEC EDGAR.
Periodo di rendicontazione: Q3 2025 ·
Metodologia ·
Ottieni questo tramite l'API